Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
The Medical Journal of Australia
|
April 5, 2012
Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda
Wendy L Lipworth, Ian Kerridge, Richard O Day
Qualitative Health Research
|
February 24, 2011
Balance, balancing, and health
Wendy L Lipworth, Claire Hooker, Stacy M Carter
Therapeutic Innovation & Regulatory Science
|
September 20, 2018
Formulating an Ethics Agenda for Drug Development, Regulation, and Utilization
Wendy L Lipworth, Ian H Kerridge, Richard O Day
The Medical Journal of Australia
|
October 9, 2013
The quality of Australian health journalism is important for public health
Christopher F C Jordens, Wendy L Lipworth, Ian H Kerridge
Social Science & Medicine (1982)
|
March 11, 2011
Journal peer review in context: A qualitative study of the social and subjective dimensions of manuscript review in biomedical publishing
Wendy L Lipworth, Ian H Kerridge, Stacy M Carter, et al.
The Medical Journal of Australia
|
August 5, 2021
Regulating complementary, unconventional and emerging treatments in Australia: a missed opportunity
Miriam Wiersma, Ian H Kerridge, Cameron L Stewart, et al.
The Medical Journal of Australia
|
August 21, 2012
Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency
Wendy L Lipworth, Ken Ho, Ian H Kerridge, et al.
The Medical Journal of Australia
|
October 19, 2011
Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment
Shafqat Inam, Wendy L Lipworth, Ian H Kerridge, et al.
The Medical Journal of Australia
|
October 8, 2011
Why is disulfiram not on the PBS?
Wendy L Lipworth, Alex D Wodak, Paul S Haber, et al.
The Medical Journal of Australia
|
October 9, 2013
The economic evaluation of personalised oncology medicines: ethical challenges
Jan R R Lewis, Wendy L Lipworth, Ian H Kerridge, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
The Medical Journal of Australia
|
April 5, 2012
Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda
Wendy L Lipworth, Ian Kerridge, Richard O Day
Qualitative Health Research
|
February 24, 2011
Balance, balancing, and health
Wendy L Lipworth, Claire Hooker, Stacy M Carter
Therapeutic Innovation & Regulatory Science
|
September 20, 2018
Formulating an Ethics Agenda for Drug Development, Regulation, and Utilization
Wendy L Lipworth, Ian H Kerridge, Richard O Day
The Medical Journal of Australia
|
October 9, 2013
The quality of Australian health journalism is important for public health
Christopher F C Jordens, Wendy L Lipworth, Ian H Kerridge
Social Science & Medicine (1982)
|
March 11, 2011
Journal peer review in context: A qualitative study of the social and subjective dimensions of manuscript review in biomedical publishing
Wendy L Lipworth, Ian H Kerridge, Stacy M Carter, et al.
The Medical Journal of Australia
|
August 5, 2021
Regulating complementary, unconventional and emerging treatments in Australia: a missed opportunity
Miriam Wiersma, Ian H Kerridge, Cameron L Stewart, et al.
The Medical Journal of Australia
|
August 21, 2012
Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency
Wendy L Lipworth, Ken Ho, Ian H Kerridge, et al.
The Medical Journal of Australia
|
October 19, 2011
Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment
Shafqat Inam, Wendy L Lipworth, Ian H Kerridge, et al.
The Medical Journal of Australia
|
October 8, 2011
Why is disulfiram not on the PBS?
Wendy L Lipworth, Alex D Wodak, Paul S Haber, et al.
The Medical Journal of Australia
|
October 9, 2013
The economic evaluation of personalised oncology medicines: ethical challenges
Jan R R Lewis, Wendy L Lipworth, Ian H Kerridge, et al.
Page
of 2